Use of PET/CT in Neuroendocrine Tumors
No contributors found.
Release Date: 2024-06-10
Neuroendocrine tumours (NETs) are rare tumours arising from cells with a neuroendocrine phenotype dispersed through the body and characterised by the overexpression of somatostatin receptors. Because of this unique feature, functional imaging plays a crucial role in the diagnosis and management of NETs. Ga-68 labelled somatostatin analogue PET/CT has demonstrated better performance than somatostatin receptor [...]
